ZNF217 and breast cancer: Taken together, lncRNA-ATB acts as a ceRNA which competes with miR-200c in TR SKBR-3 cells, then up-regulates ZEB1 and ZNF-217 and induces EMT to promote trastuzumab resistance and an invasion-metastasis cascade in BC.